CCDBF(CCDBF)
CCDBF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $8.07B | $8.46B | $8.86B |
| Low | $7.85B | $8.05B | $8.51B |
| High | $8.20B | $8.64B | $9.02B |
| EBITDA Avg | $1.84B | $1.93B | $2.02B |
| Low | $1.79B | $1.83B | $1.94B |
| High | $1.87B | $1.97B | $2.05B |
| EBIT Avg | $1.33B | $1.40B | $1.46B |
| Low | $1.29B | $1.33B | $1.40B |
| High | $1.35B | $1.43B | $1.49B |
| Net Income Avg | $871M | $942M | $1.04B |
| Low | $827M | $894M | $985M |
| High | $892M | $965M | $1.06B |
| EPS Avg | $4.96 | $5.36 | $5.91 |
| Low | $4.71 | $5.09 | $5.61 |
| High | $5.08 | $5.49 | $6.05 |
| Analysts (Rev / EPS) | 10 / 1 | 10 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.11B | $2.01B | $2.08B | $2.18B | $2.23B | $2.09B |
| Low | $2.02B | $1.93B | $1.99B | $2.08B | $2.13B | $2.00B |
| High | $2.16B | $2.06B | $2.14B | $2.23B | $2.28B | $2.14B |
| EBITDA Avg | $480M | $458M | $475M | $496M | $507M | $476M |
| Low | $459M | $438M | $454M | $475M | $485M | $455M |
| High | $492M | $470M | $487M | $509M | $520M | $488M |
| EBIT Avg | $347M | $332M | $344M | $359M | $367M | $344M |
| Low | $332M | $317M | $329M | $344M | $351M | $329M |
| High | $356M | $340M | $352M | $368M | $376M | $353M |
| Net Income Avg | $227M | $210M | $228M | $239M | $244M | $221M |
| Low | $215M | $198M | $215M | $226M | $230M | $208M |
| High | $235M | $217M | $236M | $247M | $252M | $228M |
| EPS Avg | $1.31 | $1.21 | $1.31 | $1.37 | $1.40 | $1.27 |
| Low | $1.23 | $1.14 | $1.24 | $1.30 | $1.32 | $1.20 |
| High | $1.35 | $1.25 | $1.35 | $1.42 | $1.45 | $1.31 |
| Analysts (Rev / EPS) | 9 / 1 | 8 / 1 | 4 / 1 | 4 / 1 | 5 / 1 | 4 / 1 |